Goodwill and Intangible Assets (Tables)

12 Months Ended

Dec. 31, 2021

Goodwill and Intangible Assets Disclosure [Abstract]

The following table summarizes the changes in the carrying amount of goodwill by segment as of December 31, 2021 and 2020 (in thousands):


	Clinical Services		Pharma Services		Total
Balance at December 31, 2020	$	179,534	$	31,549	$	211,083
Goodwill acquired - Trapelo	44,664		—		44,664
Goodwill acquired - Inivata	238,405		32,963		271,368
Balance at December 31, 2021	$	462,603	$	64,512	$	527,115

Schedule of Intangible Assets and Goodwill

Intangible assets consisted of the following as of December 31, 2021 and 2020 (in thousands):


		2021
	Amortization Period (years)	Cost		Accumulated Amortization		Net
Customer Relationships	7-15	$	143,101	$	45,756	$	97,345
Developed Technology	10-15	310,226		11,798		298,428
Marketing Assets	4	549		100		449
Trademarks	15	31,473		1,125		30,348
Trade Name	5	2,584		276		2,308
Trademark - Indefinite lived	—	13,447		—		13,447
Total		$	501,380	$	59,055	$	442,325

		2020
	Amortization Period (years)	Cost		Accumulated Amortization		Net
Customer Relationships	7-15	$	143,101	$	35,895	$	107,206




Trademark - Indefinite lived	—	13,447		—		13,447
Total		$	156,548	$	35,895	$	120,653

Finite-lived Intangible Assets Amortization Expense

For the years ended December 31, 2021, 2020, and 2019, amortization on the Consolidated Statements of Operations was recorded as follows (in thousands):


	2021		2020		2019
Amortization recorded in:
Cost of revenue	$	10,407	$	—	$	—
General and administrative	12,753		9,817		9,925
Total amortization	$	23,160	$	9,817	$	9,925

Schedule of Finite-Lived Intangible Assets, Future Amortization Expense

As of December 31, 2021, the estimated amortization expense related to amortizable intangible assets for each of the five following years and thereafter is as follows (in thousands):


2022	$	33,899
2023	33,899
2024	33,899
2025	33,798
2026	33,485
Thereafter	259,898
Total	$	428,878